The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

Research news of note last week included US biotech Crinetics Pharmaceuticals releasing new Phase III data on its acromegaly drug candidate Palsonify (paltusotine). AstraZeneca announced positive ...

Typhoon Wipha has toppled trees and caused major flight disruptions in Hong Kong and at some nearby airports in China as it ...

D-Day veteran and social media star "Papa Jake" Larson, who survived Omaha Beach on D-Day in 1944, has died at 102. Known for ...

Emirati conglomerate Al-Futtaim is to buy a 49.95 percent stake in Saudi Arabian franchiser Cenomi Retail in a deal worth ...

While the North Chicago, Illinois-based healthcare giant estimated its adjusted diluted earnings per share for Q3 could reach $1.28 - $1.32 compared to $1.33 in the consensus, its full-year outlook ...

July 20 recognizes PA as the second state to join the Union. Pennsylvania actually ratified the U.S. Constitution and became ...

The Burnside Plantation was filled with everything blueberry. Blueberry pie, blueberry ice cream. We even spoke with one guy ...

Andy Byron resigned from his job as CEO of Astronomer Inc., according to a statement posted on LinkedIn by the company ...

Ole Miss freshman football player Corey Adams was killed in a shooting in Tennessee, the Shelby County Sheriff's Office announced Sunday.